Synuca Therapeutics
It develops a first-in-class disease-modifying therapy for Parkinson’s disease and related brain disorders.
Aarhus, Denmarkwww.synuca.com ↗
Total raised
€1.3M
€1,300,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-03
latest 2026-03
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood19
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-03-03 | Other | €1.3M | BioInnovation Institute (BII) | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce